Overview
ODDITY Tech Q3 revenue grows 24% yr/yr, beating analyst expectations
Adjusted EPS for Q3 beats analyst expectations
Company launched new brand METHODIQ, expanding into medical care solutions
Outlook
ODDITY raises FY2025 revenue outlook to $806-809 mln
Company expects Q4 2025 revenue between $149 mln and $152 mln
ODDITY projects FY2025 adjusted EPS of $2.10-$2.12
Result Drivers
NEW BRAND LAUNCH - Successful soft launch of METHODIQ in Q3, with formal launch in November, aimed at transforming medical care with tech-driven solutions
ONLINE SALES GROWTH - Double-digit online revenue growth for IL MAKIAGE and SpoiledChild contributed to Q3 results
TECH INVESTMENTS - Ongoing development and expansion of ODDITY LABS molecule discovery platform cited as growth driver
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | Beat | $148 mln | $145.44 mln (8 Analysts) |
Q3 Adjusted EPS | Beat | $0.40 | $0.35 (8 Analysts) |
Q3 EPS | $0.28 | ||
Q3 Adjusted Net Income | Beat | $25 mln | $21.41 mln (6 Analysts) |
Q3 Adjusted EBITDA | Beat | $29 mln | $27.21 mln (8 Analysts) |
Q3 Gross Margin | 71.60% | ||
Q3 Adjusted EBITDA Margin | 19.50% |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the personal products peer group is "buy"
Wall Street's median 12-month price target for Oddity Tech Ltd is $75.00, about 51.2% above its November 18 closing price of $36.58
The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 31 three months ago
Press Release: ID:nGNX8bkVLs
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)